| Literature DB >> 18226266 |
Keiko Tanaka1, Satoshi Sasaki, Kentaro Murakami, Hitomi Okubo, Yoshiko Takahashi, Yoshihiro Miyake.
Abstract
BACKGROUND: Much research has shown that soy products inhibited various diseases. However, no published studies have examined the effects of consumption of soy and isoflavones on periodontal disease. The aim of this study was to investigate whether soy and isoflavone intake is associated with the prevalence of periodontal disease.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18226266 PMCID: PMC2267787 DOI: 10.1186/1471-2458-8-39
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Distribution of selected characteristics of 3956 Japanese females
| Variable | Number (%) |
| Age (y) | 18.1 (0.4) |
| Cigarette smoking | |
| Never | 3828 (96.8) |
| Ever | 128 (3.2) |
| Toothbrushing frequency (times/day) | |
| 1 or less | 484 (12.2) |
| 2 | 2899 (73.3) |
| 3+ | 573 (14.5) |
| Region of residence | |
| Hokkaido and Tohoku | 332 (8.4) |
| Kanto | 1322 (33.4) |
| Hokuriku and Tokai | 637 (16.1) |
| Kinki | 837 (21.2) |
| Chugoku and Shikoku | 452 (11.4) |
| Kyushu | 376 (9.5) |
| Body Mass Index (kg/m2) | |
| < 18.5 | 582 (14.7) |
| 18.5–24.9 | 3078 (77.8) |
| 25.0–29.9 | 244 (6.2) |
| 30+ | 52 (1.3) |
Distribution of daily soy and isoflavone intake in 3956 Japanese females1
| Variable | Mean (SD) |
| Total energy (kJ) | 7709.0 (2320.4) |
| Total soy product (g) | 45.0 (33.8) |
| Tofu (g) | 20.8 (22.0) |
| Tofu products (g) | 3.0 (5.8) |
| Fermented soybeans (g) | 10.2 (13.3) |
| Boiled soybeans (g) | 4.1 (9.4) |
| Miso (g) | 1.7 (5.3) |
| Miso soup (g) | 5.2 (4.6) |
| Soy protein (g) | 4.6 (3.5) |
| Isoflavone (mg) | 26.8 (21.7) |
| Daidzein (mg) | 10.1 (8.2) |
| Genistein (mg) | 16.7 (13.5) |
1Nutrition and food intake was adjusted for total energy intake using the residual method.
Odds ratios (ORs) and 95% confidence intervals (CIs) for periodontal disease by quintiles of soy product intake in 3956 Japanese females
| Quintile of intake | ||||||
| Variable | 1 | 2 | 3 | 4 | 5 | |
| Total soy product | ||||||
| Intake, g/day1 | 13.1 | 26.2 | 37.4 | 53.6 | 86.8 | |
| Prevalence | 82/791 (10.4%) | 66/791 (8.3%) | 64/791 (8.1%) | 52/791 (6.6%) | 54/792 (6.8%) | |
| Crude OR (95% CI) | 1.00 | 0.79 (0.56, 1.11) | 0.76 (0.54, 1.07) | 0.61 (0.42, 0.87) | 0.63 (0.44, 0.90) | 0.004 |
| Adjusted OR (95% CI)2 | 1.00 | 0.80 (0.57, 1.13) | 0.79 (0.56, 1.12) | 0.65 (0.45, 0.93) | 0.68 (0.47, 0.97) | 0.01 |
| Tofu | ||||||
| Intake, g/day1 | 3.2 | 8.9 | 13.6 | 24.9 | 49.7 | |
| Prevalence | 77/791 (9.7%) | 72/791 (9.1%) | 72/791 (9.1%) | 45/791 (5.7%) | 52/792 (6.6%) | |
| Crude OR (95% CI) | 1.00 | 0.93 (0.66, 1.30) | 0.93 (0.66, 1.30) | 0.56 (0.38, 0.82) | 0.65 (0.45, 0.94) | 0.002 |
| Adjusted OR (95% CI)2 | 1.00 | 0.95 (0.67, 1.33) | 0.96 (0.68, 1.34) | 0.59 (0.40, 0.86) | 0.68 (0.47, 0.98) | 0.004 |
| Tofu products | ||||||
| Intake, g/day1 | -0.6 | 0.6 | 1.5 | 3.4 | 6.7 | |
| Prevalence | 64/791 (8.1%) | 54/791 (6.8%) | 69/791 (8.7%) | 67/791 (8.5%) | 64/792 (8.1%) | |
| Crude OR (95% CI) | 1.00 | 0.83 (0.57, 1.21) | 1.09 (0.76, 1.55) | 1.05 (0.74, 1.51) | 1.00 (0.70, 1.43) | 0.60 |
| Adjusted OR (95% CI)2 | 1.00 | 0.83 (0.57, 1.21) | 1.07 (0.75, 1.54) | 1.05 (0.74, 1.51) | 0.99 (0.69, 1.43) | 0.60 |
| Fermented soybeans | ||||||
| Intake, g/day1 | 0 | 3.1 | 5.6 | 12.0 | 29.1 | |
| Prevalence | 65/791 (8.2%) | 77/791 (9.7%) | 70/791 (8.9%) | 49/791 (6.2%) | 57/792 (7.2%) | |
| Crude OR (95% CI) | 1.00 | 1.21 (0.85, 1.71) | 1.08 (0.76, 1.55) | 0.74 (0.50, 1.08) | 0.87 (0.60, 1.25) | 0.07 |
| Adjusted OR (95% CI)† | 1.00 | 1.24 (0.87, 1.76) | 1.14 (0.80, 1.63) | 0.79 (0.54, 1.17) | 0.94 (0.64, 1.36) | 0.19 |
| Boiled soybeans | ||||||
| Intake, g/day1 | -1.0 | 1.0 | 2.3 | 3.8 | 9.3 | |
| Prevalence | 68/791 (8.6%) | 65/791 (8.2%) | 60/791 (7.6%) | 56/791 (7.1%) | 69/792 (8.7%) | |
| Crude OR (95% CI) | 1.00 | 0.95 (0.67, 1.36) | 0.87 (0.61, 1.25) | 0.81 (0.56, 1.17) | 1.02 (0.71, 1.44) | 0.77 |
| Adjusted OR (95% CI)2 | 1.00 | 0.97 (0.68, 1.38) | 0.88 (0.61, 1.26) | 0.80 (0.55, 1.16) | 1.04 (0.73, 1.48) | 0.81 |
| Miso | ||||||
| Intake, g/day1 | -0.6 | 0 | 0.4 | 0.8 | 6.2 | |
| Prevalence | 63/791 (8.0%) | 63/791 (8.0%) | 58/791 (7.3%) | 66/791 (8.3%) | 68/792 (8.6%) | |
| Crude OR (95% CI) | 1.00 | 1.00 (0.70, 1.44) | 0.91 (0.63, 1.33) | 1.05 (0.73, 1.51) | 1.09 (0.76, 1.55) | 0.60 |
| Adjusted OR (95% CI)2 | 1.00 | 1.00 (0.69, 1.44) | 0.91 (0.63, 1.32) | 1.04 (0.72, 1.49) | 1.09 (0.76, 1.57) | 0.61 |
| Miso soup | ||||||
| Intake, g/day1 | 0.2 | 1.9 | 4.3 | 6.9 | 11.5 | |
| Prevalence | 70/791 (8.9%) | 78/791 (9.9%) | 64/791 (8.1%) | 43/791 (5.4%) | 63/792 (8.0%) | |
| Crude OR (95% CI) | 1.00 | 1.13 (0.80, 1.58) | 0.91 (0.64, 1.29) | 0.59 (0.40, 0.87) | 0.89 (0.62, 1.27) | 0.04 |
| Adjusted OR (95% CI)2 | 1.00 | 1.14 (0.81, 1.61) | 0.97 (0.68, 1.39) | 0.63 (0.42, 0.93) | 0.96 (0.67, 1.37) | 0.12 |
1Values for intake are medians for adjusted energy intake by the residual method for each quintile.
2Adjusted for cigarette smoking (never and ever), toothbrushing frequency (1 or less, 2, and 3+ times/day), region of residence (Hokkaido and Tohoku, Kanto, Hokuriku and Tokai, Kinki, Chugoku and Shikoku, and Kyushu), and body mass index as a continuous variable.
Odds ratios (ORs) and 95% confidence intervals (CIs) for periodontal disease by quintiles of soy protein and isoflavone intake in 3956 Japanese females
| Quintile of intake | ||||||
| Variable | 1 | 2 | 3 | 4 | 5 | |
| Soy protein | ||||||
| Intake, g/day1 | 1.3 | 2.7 | 3.8 | 5.5 | 9.0 | |
| Prevalence | 72/791 (9.1%) | 75/791 (9.5%) | 59/791 (7.5%) | 57/791 (7.2%) | 55/792 (6.9%) | |
| Crude OR (95% CI) | 1.00 | 1.05 (0.75, 1.47) | 0.81 (0.56, 1.15) | 0.78 (0.54, 1.11) | 0.75 (0.52, 1.07) | 0.03 |
| Adjusted OR (95% CI)2 | 1.00 | 1.08 (0.77, 1.53) | 0.85 (0.59, 1.22) | 0.83 (0.58, 1.20) | 0.81 (0.56, 1.17) | 0.10 |
| Isoflavone | ||||||
| Intake, mg/day1 | 7.3 | 15.3 | 21.5 | 31.9 | 52.7 | |
| Prevalence | 79/791 (10.0%) | 68/791 (8.6%) | 61/791 (7.7%) | 56/791 (7.1%) | 54/792 (6.8%) | |
| Crude OR (95% CI) | 1.00 | 0.85 (0.60, 1.19) | 0.75 (0.53, 1.07) | 0.69 (0.48, 0.98) | 0.66 (0.46, 0.94) | 0.01 |
| Adjusted OR (95% CI)2 | 1.00 | 0.86 (0.61, 1.21) | 0.79 (0.55, 1.12) | 0.73 (0.51, 1.04) | 0.71 (0.49, 1.01) | 0.04 |
| Daidzein | ||||||
| Intake, mg/day1 | 2.8 | 5.8 | 8.1 | 12.0 | 19.9 | |
| Prevalence | 77/791 (9.7%) | 69/791 (8.7%) | 62/791 (7.8%) | 56/791 (7.1%) | 54/792 (6.8%) | |
| Crude OR (95% CI) | 1.00 | 0.89 (0.63, 1.25) | 0.79 (0.55, 1.12) | 0.71 (0.49, 1.01) | 0.68 (0.47, 0.97) | 0.01 |
| Adjusted OR (95% CI)2 | 1.00 | 0.90 (0.64, 1.26) | 0.83 (0.58, 1.18) | 0.75 (0.52, 1.08) | 0.73 (0.50, 1.04) | 0.05 |
| Genistein | ||||||
| Intake, mg/day1 | 4.6 | 9.5 | 13.4 | 19.8 | 32.9 | |
| Prevalence | 78/791 (9.9%) | 68/791 (8.6%) | 62/791 (7.8%) | 56/791 (7.1%) | 54/792 (6.8%) | |
| Crude OR (95% CI) | 1.00 | 0.86 (0.61, 1.21) | 0.78 (0.55, 1.10) | 0.70 (0.49, 0.99) | 0.67 (0.46, 0.96) | 0.01 |
| Adjusted OR (95% CI)2 | 1.00 | 0.87 (0.62, 1.23) | 0.81 (0.57, 1.16) | 0.74 (0.51, 1.06) | 0.72 (0.50, 1.03) | 0.04 |
1Values for intake are medians adjusted for energy intake by the residual method for each quintile.
2Adjusted for cigarette smoking (never and ever), toothbrushing frequency (1 or less, 2, and 3+ times/day), region of residence (Hokkaido and Tohoku, Kanto, Hokuriku and Tokai, Kinki, Chugoku and Shikoku, and Kyushu), and body mass index as a continuous variable.